To report inaccuracies and omissions, please email Rowena Muñiz at rowena.muniz@tr.com
Back to top
China and Hong Kong
Firm | Deal | Value | Client | Lawyer (s) Involved |
Paul Hastings | CDH Genetech's acquisition of Sirtex Medical | $1.4 billion | CDH Genetech | Partners Associates |
Clifford Chance | Huifu Payment's IPO | HK$1.7 billion (approximately $216 million) | Huifu Payment | Partners Consultants Senior Associate Associates |
Davis Polk & Wardwell | RISE Education Cayman public offering | approximately $97.2 million |
| Partner Registered Foreign Lawyer Counsels |
Conyers Dill & Pearman | Central China Real Estate's issue of senior notes due 2020 | $86 million | Central China Real Estate | Partner Associate |
Sidley Austin | Central China Real Estate's issue of senior notes due 2020 | $86 million | Central China Real Estate |
|
Li & Partners | Central China Real Estate's issue of senior notes due 2020 | $86 million | Central China Real Estate |
|
Commerce & Finance Law Offices | Central China Real Estate's issue of senior notes due 2020 | $86 million | Central China Real Estate |
|
Conyers Dill & Pearman | 21st Century Education Group's IPO | HK$406.8 million (approximately $52 million) | 21st Century Education Group | Partner |
Luk & Partners | 21st Century Education Group's IPO | HK$406.8 million (approximately $52 million) | 21st Century Education Group |
|
Morgan, Lewis & Bockius | 21st Century Education Group's IPO | HK$406.8 million (approximately $52 million) | 21st Century Education Group |
|
India
Firm | Deal | Value | Client | Lawyer (s) Involved |
AZB & Partners | Singapore Amaravati Investment and Amaravati Development Corporation's acquisition of stake in Amaravati Development Partners | 31.4 billion rupees (approximately $459 million) | Ascendas-Singbridge and Sembcorp Development | Partner Senior Associate Associate |
AZB & Partners | Softbank Group's acquisition of stake in PayTM E-Commerce | 26 billion rupees (approximately $400 million) | SoftBank Group | Partner Senior Associates |
AZB & Partners | Reliance Industries' acquisition of shares in Embibe | 11.8 billion rupees (approximately $180 million) | Reliance Industries | Partners Senior Associate Associates |
Advaita Legal | Chung-Hsin Electric & Machinery Manufacturing of Taiwan's long-term supply agreement for hydrogen fuel cells with Vodafone India | $100 million | Chung-Hsin Electric & Machinery Manufacturing (CHEM) | Principal |
KMPG | Chung-Hsin Electric & Machinery Manufacturing of Taiwan's long-term supply agreement for hydrogen fuel cells with Vodafone India | $100 million | Chung-Hsin Electric & Machinery Manufacturing (CHEM) |
|
J. Sagar Associates | Craftsman Automation's proposed IPO | 400 crore (approximately $60 million) | ICICI Securities, IIFL Holdings and SBI Capital Markets | Partners Senior Associates Associates |
J. Sagar Associates | Avana Logistek's IPO | 300 crore (approximately $45 million) | ICICI Securities and Axis Capital | Partners Senior Associates Associates |
AZB & Partners | Affiliates of SeaLink Capital's acquisition of stake in Surya Children's Medicare | 1.83 billion rupees (approximately $27.17 million) | SeaLink Capital Partners | Partner Counsel Senior Associate |
AZB & Partners | SQS Germany's acquisition of control and voting share capital of SQS India | 1.35 billion rupees (approximately $20.7 million) | SQS Software Quality Systems | Partners |
AZB & Partners | JM Financial Asset Reconstruction Company's acquisition of Axis Bank's receivables arising out of credit facilities from Sevenhills Healthcare | Confidential. In excess of $10 million | Axis Bank | Partners Senior Associate |
AZB & Partners | ParkerGale's acquisition of a carve-out business from Gartner (US) and CEB India | Confidential. In excess of $10 million | ParkerGale | Partners Senior Associates Associates |
Advaita Legal | Aashiyaan Housing Development Finance's seed capital from Oikocredit and Insitor | 13.5 crore (approximately $2 million) | Aashiyaan Housing & Development Finance | Principal Associates |
Advaita Legal | Brenntag's acquisition of stake in Raj Petro Specialties | Undisclosed | Brenntag (Holding) | Principal Associates |
AZB & Partners | The Federal Bank's acquisition of stake in Equirus Capital | Undisclosed | Equirus Capital | Partners Senior Associate |
Japan
Firm | Deal | Value | Client | Lawyer (s) Involved |
Davis Polk & Wardwell | Shionogi's strategic collaboration with Sage Therapeutics for the clinical development and commercialisation of SAGE-217 | Undisclosed | Shionogi | Counsels Associate |
Singapore
Firm | Deal | Value | Client | Lawyer (s) Involved |
Allen & Gledhill | Mapletree North Asia Commercial Trust Management's acquisition of effective interest in six freehold commercial real estate Japan assets of Tsubaki 1 | S$735.8 million (approximately $544 million) | Mapletree North Asia Commercial Trust Management | Partners |
Allen & Gledhill | Mapletree North Asia Commercial Trust Management's equity fund raising | S$330 million (approximately $244 million) | Mapletree North Asia Commercial Trust Management | Partners |
Allen & Gledhill | HSBC Institution Trust Services' issuance of notes due 2025 | S$200 million (approximately $150 million) | HSBC Institutional Trust and Ascendas Funds Management | Partners |
Back to top
South Korea
Firm | Deal | Value | Client | Lawyer (s) Involved |
Davis Polk & Wardwell | Shionogi's strategic collaboration with Sage Therapeutics for the clinical development and commercialisation of SAGE-217 | Undisclosed | Shionogi | Counsels Associate |
Taiwan
Firm | Deal | Value | Client | Lawyer (s) Involved |
Advaita Legal | Chung-Hsin Electric & Machinery Manufacturing of Taiwan's long-term supply agreement for hydrogen fuel cells with Vodafone India | $100 million | Chung-Hsin Electric & Machinery Manufacturing (CHEM) | Principal |
KMPG | Chung-Hsin Electric & Machinery Manufacturing of Taiwan's long-term supply agreement for hydrogen fuel cells with Vodafone India | $100 million | Chung-Hsin Electric & Machinery Manufacturing (CHEM) |
|
Davis Polk & Wardwell | Shionogi's strategic collaboration with Sage Therapeutics for the clinical development and commercialisation of SAGE-217 | Undisclosed | Shionogi | Counsels Associate |
